Nicotinic acid: A new look at an old drug John A. Farmer OriginalPaper 15 February 2009 Pages: 87 - 92
GLP-1 agonist-based therapies: An emerging new class of antidiabetic drug with potential cardioprotective effects Melanie SulistioCurtis CarothersRobert Chilton OriginalPaper 15 February 2009 Pages: 93 - 99
The relationship of statins to rhabdomyolysis, malignancy, and hepatic toxicity: Evidence from clinical trials Alawi A. Alsheikh-AliRichard H. Karas OriginalPaper 15 February 2009 Pages: 100 - 104
Aspirin resistance: An update Gilead I. LancasterJanardhan SrinivasanHitender Jain OriginalPaper 15 February 2009 Pages: 105 - 110
The role of CT angiography in risk stratification for atherosclerosis Axel SchmermundAnnett MagedanzThomas Voigtländer OriginalPaper 15 February 2009 Pages: 111 - 117
The role of statin therapy in the management of cardiomyopathies Kumudha RamasubbuJohn A. Farmer OriginalPaper 15 February 2009 Pages: 118 - 123
The role of C-reactive protein polymorphisms in inflammation and cardiovascular risk Fadi G. HageAlexander J. Szalai OriginalPaper 15 February 2009 Pages: 124 - 130
Monocyte chemoattractant protein-1/CCL2 as a biomarker in acute coronary syndromes Carlos Gonzalez-QuesadaNikolaos G. Frangogiannis OriginalPaper 15 February 2009 Pages: 131 - 138
Pulmonary arterial hypertension Aydin UzunpinarMehmet Cilingiroglu OriginalPaper 15 February 2009 Pages: 139 - 145
Drug-eluting stents and vulnerable plaque Mehmet CilingirogluFaisal Khan OriginalPaper 15 February 2009 Pages: 146 - 148
Lipid management: Considerations in acute coronary syndrome Venkateshwar R. PolsaniSalim S. ViraniVijay Nambi OriginalPaper 15 February 2009 Pages: 149 - 156